Is Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors (LMD-BT) as Good as Conventional Inpatient PDD Guided Transurethral Tumor Resection in Patients With Low Grade Non-invasive (Ta) Bladder Tumors?
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 248
- Locations
- 2
- Primary Endpoint
- Tumor recurrence histological identified in biopsy obtained during cystoscopy
Study Overview
Brief Summary
This study compare the efficacy of conventional photodynamic (PDD) guided transurethral bladder tumor resection in the operating theatre with outpatient PDD guided laser destruction of bladder tumors through flexible cystoscopes.
Detailed Description
A prospective randomized two-part clinical trial comprising patients with recurrent pTa low grade bladder tumors.
Study objectives and purpose:
- 1st Objective: To evaluate whether small pTa bladder tumours can be removed with diode laser in an outpatient department with similar efficacy as by TUR-BT resection in the operating theatre.
- 2nd Objective: To evaluate the patients experience of symptoms during laser treatment in the outpatient department (OPD) using quality of life (QOL) questionnaires (symptom evaluation) and Visual Analog Scale Score (pain evaluation).
- 3rd Objective: To evaluate whether patients prefer standard transurethral bladder tumor resection (TUR-BT) in the operating theatre (OT) or laser treatment in the OPD.
- 4th Objective: To evaluate the safety after laser treatment in the OPD.
Efficacy:
- 1st Endpoint: Proportion of patients with no tumor tissue in the bladder after 4 months and 12 months.
- 2nd Endpoint: Visual Analog Scale Score (pain evaluation) in patients having tumor removed by laser in the OPD.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Ta low grade bladder tumor recurrences
- •Up to a tumor size of 1,5 cm
- •Up to 6 tumors
- •Eligible patients for TUR-BT in GA
Exclusion Criteria
- •Patients with porphyria
- •Known hypersensitivity to Hexvix® or porfhyrins
- •Use of concomitant anticoagulants as Marevan, Marcoumar, and Pradaxa
- •Macroscopic hematuria
- •Pregnant or breast feeding women
- •Expected poor compliance estimated by the investigators
- •Patients < 18 years
- •Patients who do not read or understand Danish
Outcomes
Primary Outcomes
Tumor recurrence histological identified in biopsy obtained during cystoscopy
Time Frame: 4 months
Numbers (%) of patients vith histological proven recurrence of bladder tumor after 4 months
Secondary Outcomes
- Pain during laser treatment(Evaluated immediately after laser treatment)
- Side effects to laser treatment.(2 weeks)
- Lower urinary symptoms caused by laser treatment.(2 weeks)
Investigators
Gregers Gautier Hermann
Consultant Urologist
University Hospital Bispebjerg and Frederiksberg
